STERILE manufacturing specialist SCM Pharma is set to expand its vial filling capability after placing a major new order to help deal with several clinical trials and commercial supply contract wins.

-New service ensures rapid delivery of small volume clinical trial materials, solving a critical bottleneck in drug development- SPOKANE, Wash.–(BUSINESS WIRE)–February 12, 2025– Selkirk Pharma, Inc., ...

PCI Pharma Services ("PCI") – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a ...

The "Fill Finish Pharmaceutical Contract Manufacturing Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Fill Finish Service Offered, Type of FDF, API Potency, Type of ...

Injectable liquid filling machines have become essential equipment across modern pharmaceutical production lines. These machines support the precise filling of sterile liquids into vials, syringes, ...

The "Fill Finish Pharmaceutical Contract Manufacturing Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Fill Finish Service Offered, Type of FDF, API Potency, Type of ...

Fill-finish Pharmaceutical Contract Manufacturing Market · GlobeNewswire Inc. Dublin, March 04, 2026 (GLOBE NEWSWIRE) -- The "Fill-finish Pharmaceutical Contract Manufacturing Market - Global Forecast ...

SPOKANE, Wash.--(BUSINESS WIRE)--Selkirk Pharma, Inc., a privately held U.S. pharmaceutical manufacturer specializing in the fill and finish of injectable drugs, including vaccines and biological ...

The growth trajectory is closely linked to the rapid expansion of injectable therapies, including vaccines, biologics, and treatments for chronic diseases. As healthcare systems prioritize sterile ...

NEWARK, Del., March 10, 2026 /PRNewswire/ -- Future Market Insights (FMI) projects the global injectable liquid filling machines market is entering a period of steady expansion as pharmaceutical ...